Skip to main content
SpringerLink
Log in

Experimental Medicine in Psychiatry New Approaches in Schizophrenia, Depression and Cognition

  • Chapter
Translational Neuropsychopharmacology

Part of the book series: Current Topics in Behavioral Neurosciences ((CTBN,volume 28))

Abstract

The use of experimental medicine studies to bridge the gap between Phase 1 and 2 drug trials and so to enhance translation of basic neuroscience studies using experimental animals to the clinic is proposed. Illustrative examples are provided for affective disorders and schizophrenia in relation also to cognitive dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, Laruelle M (2000) Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 97:8104–8109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alvarez E, Perez V, Dragheim M, Loft H, Artigas F (2012) A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. Int J Neuropsychopharmacol/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 15(5):589–600. 10.1017/S1461145711001027

  • Andersson JLR, Jenkinson M, Smith S (2010) Non-linear registration, aka spatial normalisation. FMRIB technical report TR07JA2

    Google Scholar 

  • Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH.BRIDGE Study Group (2011) Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry 68:791–798

    Google Scholar 

  • Antonova E, Parslow D, Brammer M, Dawson GR, Jackson SH, Morris RG (2009) Age-related neural activity during allocentric spatial memory. Memory 2:125–143

    Google Scholar 

  • Antonova E, Parslow D, Brammer M, Simmons A, Williams S, Dawson GR, Morris R (2011) Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze. J Psychopharmacol 9:1256–1265

    Google Scholar 

  • Barch DM (2004) Pharmacological manipulation of human working memory. Psychopharmacology (Berl) 174:126–135

    Google Scholar 

  • Barkus E, Stirling J, Hopkins R, Lewis S (2006a) The presence of neurological soft signs along the psychosis proneness continuum. Schizophr Bull 32:573–577

    Article  PubMed  PubMed Central  Google Scholar 

  • Barkus E, Stirling J, Hopkins R, McKie S, Lewis S (2007) Cognitive and neural processes in non-clinical auditory hallucinations. Brit. J Psychiatry 51:s76–s81

    Article  Google Scholar 

  • Barkus EJ, Stirling J, Hopkins RS, Lewis S (2006b) Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39:175–178

    Article  CAS  PubMed  Google Scholar 

  • Barrantes-Vidal N, Gross GM, Sheinbaum T, Mitjavila M, Ballespí S, Kwapil TR (2013) Positive and negative schizotypy are associated with prodromal and schizophrenia-spectrum symptoms. Schizophr Res 145:50–55

    Article  PubMed  Google Scholar 

  • Boulenger J-P, Loft H, Olsen CK (2014) Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder. Int Clin Psychopharmacol 29(3):138–149

    Google Scholar 

  • Burton SC (2005) Strategies for improving adherence to second-generation antipsychotics in patients with schizophrenia by increasing ease of use. J Psychiatric Pract 11(6):369–378.

    Google Scholar 

  • Campbell S, Marriott M, Nahmias C, MacQueen GM (2004) Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 161:598–607

    Google Scholar 

  • Chapman LJ, Kwapil TR (1995) Scales for the measurement of schizotypy. In: Raine A, Lencz T, Mednick SA (eds) Schizotypal personality. Cambridge University Press, Cambridge, pp 79–106

    Chapter  Google Scholar 

  • Channon S, Baker JE, Robertson MM (1993) Working memory in clinical depression—an experimental study. Psychol Med 23:87–91

    Google Scholar 

  • Connell PH (1958) Amphetamine psychosis. Chapman and Hall, London

    Google Scholar 

  • Conradi HJ, Ormel J, de Jonge P (2011) Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med 41:1165–1167

    Article  CAS  PubMed  Google Scholar 

  • Dawson GR, Goodwin GM (2005) Experimental medicine in psychiatry. J Psychopharmacol 19:565–566

    Google Scholar 

  • Ettinger U, Kumari V, Crawford TJ, Corr PJ, Das M, Zachariah E, Hughes C, Sumich AL, Rabe-Hesketh S, Sharma T (2004) Smooth pursuit and antisaccade eye movements in siblings discordant for schizophrenia. J Psychiatry Res 38:177–184.

    Google Scholar 

  • Ettinger U, Picchioni M, Hall MH, Schulze K, Toulopoulou T, Landau S, Crawford TJ, Murray RM (2006) Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study. Am J Psychiatry 163:543–545

    Google Scholar 

  • Ettinger U, Kumari V, Crawford TJ, Flak V, Sharma T, Davis RE, Corr PJ (2005) Saccadic eye movements, schizotypy, and the role of neuroticism. Biol Psychol 68:61–78

    Article  PubMed  Google Scholar 

  • Fitzgerald PB, Srithiran A, Benitez J, Daskalakis ZZ, Oxley TJ, Kulkarni J, Egan GF (2008) An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder. Human Brain Mapping, 29(4):490–501. doi:10.1002/hbm.20414

  • Gooding DC (1999) Antisaccade task performance in questionnaire-identified schizotypes. Schizophr Res 35:157–166

    Article  CAS  PubMed  Google Scholar 

  • Gorwood P, Corruble E, Falissard B, Goodwin GM (2008) Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am J Psychiatry 165:731–739

    Article  PubMed  Google Scholar 

  • Gould TD, Manji HK (2004) The molecular medicine revolution and psychiatry: bridging the gap between basic neuroscience research and clinical psychiatry. J Clin Psychiatry 598-604

    Google Scholar 

  • Green MF (2006) Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 67:e12

    Article  PubMed  Google Scholar 

  • Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophr Bull 26:119–136

    Article  CAS  PubMed  Google Scholar 

  • Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR (2004) Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 56:301–307

    Article  PubMed  Google Scholar 

  • Haddon JE, George DN, Grayson L, McGowan C, Honey RC, Killcross S (2011) Impaired conditional task performance in a high schizotypy population: relation to cognitive deficits. Q J Exp Psychol 64:1–9

    Article  Google Scholar 

  • Haddon JE, George DN, Killcross S (2008) Contextual control of biconditional task performance: evidence for cue and response competition in rats. Q J Exp Psychol 61:1307–1320

    Article  CAS  Google Scholar 

  • Harmer CJ, O’Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke et al (2009) Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry 166:1178–1184

    Google Scholar 

  • Harvey PD, Green MF, Nuechterlein KH (2010) Latest developments in the matrics process. Psychiatry (Edgmont) 7:49–52

    Google Scholar 

  • Hasselbalch BJ, Knorr U, Kessing LV (2011) Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord 134:20–23

    Article  PubMed  Google Scholar 

  • Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12:426–445

    Article  CAS  PubMed  Google Scholar 

  • Henigsberg N, Mahableshwarkar AR, Jacobsen P, Chen Y, Thase ME (2012) A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder. J Clin Psychiatry 73(7):953–959. doi:10.4088/JCP.11m07470

  • Holahan AL, O’Driscoll GA (2005) Antisaccade and smooth pursuit performance in positive- and negative-symptom schizotypy. Schizophr Res 76:43–54

    Article  PubMed  Google Scholar 

  • Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009) Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 66:13–20

    Article  PubMed  Google Scholar 

  • Hutton SB, Ettinger U (2006) The antisaccade task as a research tool in psychopathology: a critical review. Psychophysiology 43:302–313

    Article  PubMed  Google Scholar 

  • Jensen JB, du Jardin KG, Song D, Budac D, Smagin G, Sanchez C, Pehrson AL (2014) Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation. Eur Neuropsychopharmacol 24:148–159. doi:10.1016/j.euroneuro.2013.10.011

  • Juckel G, Schlagenhauf F, Koslowski M, Wustenberg T, Villringer A, Knutson B, Wrase J, Heinz A (2006) Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 29:409–416

    Article  PubMed  Google Scholar 

  • Kapur S, Mamo D (2003) Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 27:1081–1090

    Article  CAS  PubMed  Google Scholar 

  • Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160:13–23

    Article  PubMed  Google Scholar 

  • Katona C, Hansen T, Olsen CK (2012) A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol 27(4):215–223. doi:10.1097/YIC.0b013e3283542457

  • Kerestes R, Ladouceur CD, Meda S, Nathan PJ, Blumberg HP, Maloney K, Ruf B, Saricicek A, Pearlson GD, Bhagwagar Z, Phillips ML (2011) Abnormal prefrontal activity subserving attentional control of emotion in remitted depressed patients during a working memory task with emotional distracters. Psychological Medicine, Cambridge University Press

    Google Scholar 

  • Klein D, Davis J (1969) Diagnosis and drug treatment of psychiatric disorders. Williams & Wilkins, Baltimore 4:24

    Google Scholar 

  • Koenigsberg HW, Harvey PD, Mitropoulou V, Schmeidler J, New AS, Goodman M, Silverman JM, Serby M, Schopick F, Siever LJ (2002) Characterizing affective instability in borderline personality disorder. Am J Psychiatry 159:784–788

    Article  PubMed  Google Scholar 

  • Koychev I, McMullen K, Lees J, Dadhiwala R, Grayson L, Perry C, Schmechtig A, Walters J, Craig KJ, Dawson GR, Dourish CT, Ettinger U, Wilkinson L, Williams S, Deakin JF, Barkus E (2012) A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study. Eur Neuropsychopharmacol 22:469–481

    Article  CAS  PubMed  Google Scholar 

  • Kremen WS, Seidman LJ, Faraone SV, Toomey R, Tsuang MT (2000) The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol 109:743–752

    Article  CAS  PubMed  Google Scholar 

  • Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D’Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235–9240

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Laruelle M, Abi-Dargham A (1999) Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol 13:358–371

    Article  CAS  PubMed  Google Scholar 

  • Lee J, Park S (2005) Working memory impairments in schizophrenia: a meta-analysis. J Abnorm Psychol 114:599–611

    Google Scholar 

  • Leigh J and Zee DS (1999) The neurology of eye movements. Philadelphia, FA Davis Company

    Google Scholar 

  • Levy DL, Sereno AB, Gooding DC, O’Driscoll GA (2010) Eye tracking dysfunction in schizophrenia: characterization and pathophysiology behavioural neurobiology of schizophrenia and its treatment. Springer, Berlin

    Google Scholar 

  • Liddle PF (1987) The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 151:145–151

    Article  CAS  PubMed  Google Scholar 

  • Lieberman JA (2007) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials. J Clin Psychiatry 68:e04

    Article  PubMed  Google Scholar 

  • Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS (2015) A Randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. doi:10.1038/npp.2015.52

  • Mason O, Claridge G (2006) The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE): further description and extended norms. Schizophr Res 82:203–211

    Article  PubMed  Google Scholar 

  • Matthysse S (1973) Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed Proc 32:200–205

    Google Scholar 

  • McCabe C, Mishor Z (2011) Antidepressant medications reduce subcortical–cortical resting-state functional connectivity in healthy volunteers. NeuroImage 57:1317–1323

    Google Scholar 

  • McDermott LM, Ebmeier KP (2009) A meta-analysis of depression severity and cognitive function. J Affect Disord 119:1–8

    Article  PubMed  Google Scholar 

  • McGowan S, Lawrence AD, Sales T, Quested D, Grasby P (2004) Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F] fluorodopa study. Arch Gen Psychiatry 61:134–142

    Article  PubMed  Google Scholar 

  • McIntyre RS, Lophaven S, Olsen CK (2014) A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 17(10):1557–1567. doi:10.1017/S1461145714000546

  • Miller DD (2004) Atypical antipsychotics: sleep, sedation, and efficacy. Prim Care Companion J Clin Psychiatry 6(Suppl 2):3–7

    Google Scholar 

  • Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79–104

    Article  CAS  PubMed  Google Scholar 

  • Morris RGM (1981) Spatial localisation does not depend on the presence of local cues. Learn and Motiv 12:239–260

    Google Scholar 

  • Nelson MT, Seal ML, Pantelis C, Phillips LJ (2013) Evidence of a dimensional relationship between schizotypy and schizophrenia: a systematic review. Neurosci Biobehav Rev 37:317–327

    Article  CAS  PubMed  Google Scholar 

  • O’Driscoll GA, Lenzenweger MF, Holzman PS (1998) Antisaccades and smooth pursuit eye tracking and schizotypy. Arch Gen Psychiatry 55:837–843

    Article  PubMed  Google Scholar 

  • Parslow DM, Rose D, Brooks B, Fleminger S, Gray JA, Giampietro V, Brammer MJ, Williams S, Gasston D, Andrew C, Vythelingum GN, Loannou G, Simmons A, Morris RG (2004) Allocentric spatial memory activation of the hippocampal formation measured with fMRI. Neuropsychology 18:450–461

    Google Scholar 

  • Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD (2006) Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442:1042–1045

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rado S (1953) Dynamics and classification of disordered behaviour. Am J Psychiatry 110:406–416

    Article  CAS  PubMed  Google Scholar 

  • Raine A (1991) The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 17:555–564

    Article  CAS  PubMed  Google Scholar 

  • Raine A (2006) Schizotypal personality: neurodevelopmental and psychosocial trajectories. Annu Rev Clin Psychol 2:291–326

    Google Scholar 

  • Reilly JL, Lencer R, Bishop JR, Keedy S, Sweeney JA (2008) Pharmacological treatment effects on eye movement control. Brain Cogn 68:415–435

    Article  PubMed  PubMed Central  Google Scholar 

  • Rock PL, Roiser JP, Riedel WJ, Blackwell AD (2013) Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med 44:2029–2034

    Article  PubMed  Google Scholar 

  • Roiser JP, Elliott R, Sahakian BJ (2012) Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 37:117–136

    Article  CAS  PubMed  Google Scholar 

  • Roiser JP, Sahakian BJ (2013) Hot and cold cognition in depression. CNS Spectr 18:139–149

    Article  PubMed  Google Scholar 

  • Roiser JP, Stephan KE, den Ouden HE, Barnes TR, Friston KJ, Joyce EM (2009) Do patients with schizophrenia exhibit aberrant salience? Psychol Med 39:199–209

    Google Scholar 

  • Ross RG, Harris JG, Olincy A (2000) Radant A.Eye movement task measures inhibition and spatial working memory in adults with schizophrenia, ADHD, and a normal comparison group. Psychiatry Res 95:35–42

    Google Scholar 

  • Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3:353–359

    Article  CAS  PubMed  Google Scholar 

  • Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F, Janssen B, Maurer K, Häfner H, Gaebel W, Möller HJ, Maier W, Klosterkötter J (2007) LIPS study group. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry Suppl 51:s88–95

    Google Scholar 

  • Rust J (1988) The rust inventory of schizotypal cognitions (RISC). Schizophr Bull 14:317–322

    Article  CAS  PubMed  Google Scholar 

  • Rybakowski JK, Drozdz W, Borkowska A (2007) Low dose risperidone in the treatment of schizophrenia-like symptoms in high-risk subjects. Human Psychopharmacology 22:407–412

    Google Scholar 

  • Sahakian BJ, Bruhl AB, Cook J, Killikelly C, Savulich G, Piercy T, Hafizi S, Perez J, Fernandez-Egea E, Suckling J, Jones PB (2015) The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people. Philos Trans R Soc B 370

    Google Scholar 

  • Sanchez C, Asin KE, Artigas F (2015) Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol Ther 145:43–57

    Google Scholar 

  • Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM, Kester DB, Stafiniak P (1991) Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatry 48:618–624

    Article  CAS  PubMed  Google Scholar 

  • Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A (2008) Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology 196:673–684

    Article  CAS  PubMed  Google Scholar 

  • Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B (1997) Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280:83–97

    Google Scholar 

  • Schultz W (2015) Neuronal reward and decision signals: from theories to data. Physiol Rev 95:853–951

    Google Scholar 

  • Seeman P (2013) Schizophrenia and dopamine receptors. Eur Neuropsychopharmacol 23:999–1009

    Article  CAS  PubMed  Google Scholar 

  • Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM (1998) Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression: controlled magnetic resonance imaging study. Br J Psychiatry 172:527–532

    Google Scholar 

  • Sheline YI, Gado MH, Kraemer HC (2003) Untreated depression and hippocampal volume loss. Am J Psychiatry 160:1516–1518

    Google Scholar 

  • Steeds H, Carhart-Harris RL, Stone JM (2015) Drug models of schizophrenia. Ther Adv Psychopharmacol 5:43–58

    Google Scholar 

  • Stip E (2002) Happy birthday neuroleptics! 50 years later: la folie du doute. Eur Psychiatry 17:115–119

    Article  PubMed  Google Scholar 

  • Stirling J, Barkus E, Lewis S (2007) Hallucination proneness, schizotypy and meta-cognition. Behav Res Ther 45:1401–1408

    Article  PubMed  Google Scholar 

  • Trestman RL, Keefe RS, Mitropoulou V, Harvey PD, deVegvar ML, Lees-Roitman S, et al. (1995) Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. Psychiatry Res 59:127–136

    Google Scholar 

  • Tsuang MT, Stone WS, Seidman LJ, Faraone SV, Zimmet S, Wojcik J, Kelleher JP, Green AI (1999) Treatment of nonpsychotic relatives of patients with schizophrenia: four case studies Biological Psychiatry 45:1412–1418

    Google Scholar 

  • Umbricht D, Alberati D, Martin-Facklam M, Borroni E, Youssef EA, Ostland M, Santarelli L (2014) Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study. JAMA Psychiatry 71:637–646

    Article  CAS  PubMed  Google Scholar 

  • Videbech P, Ravnkilde B (2004) Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161:1957–1966

    Article  PubMed  Google Scholar 

  • Williams JH, Wellman NA, Geaney DP, Feldon J, Cowen PJ, Rawlins JN (1997) Haloperidol enhances latent inhibition in visual tasks in healthy people. Psychopharmacology (Berlin) 133(3):262–268

    Google Scholar 

  • Ziauddeen H, Murray GK (2010) The relevance of reward pathways for schizophrenia. Curr Opin Psychiatry 23:91–96

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. P1vital LTD, Manor House, Howbery Park, Wallingford, Oxfordshire, OX10 8BA, UK

    Gerard R. Dawson

Authors
  1. Gerard R. Dawson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerard R. Dawson .

Editor information

Editors and Affiliations

  1. University of Cambridge, Cambridge, UK

    Trevor W. Robbins

  2. University of Cambridge, Cambridge, UK

    Barbara J. Sahakian

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Dawson, G.R. (2015). Experimental Medicine in Psychiatry New Approaches in Schizophrenia, Depression and Cognition. In: Robbins, T.W., Sahakian, B.J. (eds) Translational Neuropsychopharmacology. Current Topics in Behavioral Neurosciences, vol 28. Springer, Cham. https://doi.org/10.1007/7854_2015_5016

Download citation

Publish with us

Policies and ethics

Search

Navigation